FDA Clearance Tracker · K254035
Mayumi Thrombectomy System
Last checked: Nov 19, 2026Latest source record: Sep 3, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 3, 2026
Substantially Equivalent
Time to decision
261 days
Received Dec 16, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K254035
- Device name
- Mayumi Thrombectomy System
- Applicant location
- Aliso Viejo, CA
- Received
- Dec 16, 2025
- Decided
- Sep 3, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Aspiration Thrombectomy Catheter (QEZ)
- Device class
- Class II
- Regulation
- 21 CFR 870.5150
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QEZ. The earliest in FDA's data is K983534, decided Feb 26, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K254035
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for MicroVention, Inc., d/b/a Terumo Neuro
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261808 · Decided Jun 30, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261549 · Decided Jun 9, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.